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Toxicological Properties of Lead
by Terri Damstra
The pathological effects of lead on the renal, nervous, reproductive, endocrine, and immune systems
have been reviewed. Emphasis is placed on reported subclinical effects due to chronic, low-level lead
exposure. The crucial issue of whether subtle behavioral, inteUlectual, and developmental impairment
occurs inyoungchildren, as aresultoflead-induced CNSdamage isdiscussedindeta;l. This issueremains
unresolved. Further studies are needed in order to determine the long-term health effects ofcontinuous,
low-level lead exposure.
Introduction
Lead has been recognized for centuries as a gen-
eral metabolic poison. Acute lead poisoning results
in a well-characterized syndrome manifested in
adults by colic, anemia, headache, fatigue, gum
line, and peripheral neuropathy (1). In children, the
symptoms of acute lead intoxication include vomit-
ing, anorexia, lethargy, convulsions, coma, and en-
cephalopathy (2). Such symptoms oflead poisoning
usually do not occur until blood lead levels exceed
80,g/100 ml. Therapeutic intervention at this stage
is only partially successful in preventing permanent
injury. Although occasional episodes of classical
lead poisoning still occur, particularly in young
children, acute exposure is becoming a diminishing
problem. Of greater concern is the possibility that
continuous exposure to lower levels of lead, as a
result of widespread environmental contamination
may result in adverse health effects. Although other
systems may also be affected, it has been well
documented that lead impairs the renal,
hematopoietic, and nervous system (3). Renal ef-
fects are seen only in subjects with long-term, high
exposure, and in association with other symptoms
oflead toxicity (4). Adverse subclinical effects such
as an excretion of porphyrins and their precursors
into the urine have been observed in the
hematopoietic system; these effects were discussed
in the previous article (5). It is presently not known
whether subtle CNS impairment can occur at lead
levels before effects are observed in the
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hematopoietic system. Simple neurochemical tests
for signaling early metabolic changes in the nervous
system, comparable to the tests used to measure
changes in the hematopoietic system, are currently
unavailable. In general, CNS impairment has been
assessed through the use ofvarious functional tests.
Since, reports concerning CNS damage due to
asymptomatic lead exposure have been conflicting
and controversial, this review has emphasized this
crucial aspect of lead toxicity.
Effects of Lead on the
Nervous System
Encephalopathy
The neurotoxicity oflead at high levels ofexpos-
ure has been well documented for both man and
animal species. Acute encephalopathy is one ofthe
most serious consequences of plumbism, since
permanent impairment of the central nervous sys-
tem may occur, particularly in young children.
Byers and Lord (6) showed that lead en-
cephalopathy produced some irreversible neurolog-
ical and psychological sequelae in 19 out of20 chil-
dren. The American Academy of Pediatrics (7) es-
timates that 25% of children affected with lead en-
cephalopathy will suffer permanent damage to the
central nervous system. This damage is usually re-
flected in behavioral and educationalabnormalities,
with or without accompanying mental retardation.
Perlstein and Attala (8) observed that 82% of chil-
dren with a history of lead encephalopathy experi-
enced recurrent seizures and mental retardation.
Mellins and Jenkins (9) and Bradley and Baumgart-
ner (10) found that 60-80% of children treated for
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tion. Smith (11) found abnormal EEG tracings in six
of ten children affected with encephalopathy. Chil-
dren who have already experienced lead en-
cephalopathy and are subsequently re-exposed to
lead, will almost certainly develop permanent CNS
damage (12). Recently, Albert et al. (13) and
Rummo (14) have reconfirmed the deterimental ef-
fects of severe lead poisoning on the subsequent
behavior and intellectual functioning of children.
Neurological Diseases
Warren (15) has speculated on a link between
lead exposure and several chronic neurological dis-
eases. Cone (16) reported that the cerebrospinal
fluid of multiple sclerosis patients contained ele-
vated lead levels; however, Butler (17) and Wes-
terman (18), using more sensitive techniques for
lead analysis, were unable to show an association
between lead absorption and multiple sclerosis. The
possibility of an association has been revived by
Warren (15, 19, 20) by demonstrating that certain
geographical areas with high environmental lead
levels have a high incidence ofmultiple sclerosis. A
number ofstudies (21-23) have reported an associa-
tion of exposure to lead with motor neuron disease,
but the etiological role of lead is not clear in these
studies. Lead insult has also been associated with
scrapie and swayback in sheep and kuru and amyo-
tropic lateral sclerosis in humans (15). These sug-
gestive associations warrant further investigation,
but to date, controlled, positive studies are lacking.
Peripheral Neuropathy
Animal studies have shown that lead produces
segmental demyelination (24-26), and interferes
with myelin metabolism in tissue culture (27). Such
damage to the myelin sheath has been shown to
impair nerve function. Catton, et al. (28) and
Seppalainen and Hernberg (29), using sensitive
electrophysiological techniques, observed impaired
motor nerve conduction velocities in neurologically
symptom-free lead workers, whose blood lead
levels exceeded 70 ,ug/100 ml. The recent studies by
Sepalainen et al. (30) also revealed a slowing of
motor conduction velocity of the median and ulnar
nerves of asymptomatic workers whose blood lead
values had never exceeded 70,ug/100 ml. Abnormal
measurements began to occur at blood lead levels of
50-60,ug/l00 ml. Although a dose-reponse relation-
ship between a slowing of motor nerve conduction
velocity and blood lead values has not yet been
adequately documented, these preliminary findings
suggest that the acceptable level of blood lead (70
/ig/10() ml) for occupationally exposed workers may
need to be reevaluated.
Peripheral neuropathy has been considered to be
a rare occurrence in children with lead intoxication
(31). However, Feldman et al. (32) suggested that
childhood neuropathy may be overlooked and over-
shadowed by the clinical symptoms of en-
cephalopathy. These authors observed slightly re-
duced motor nerve conduction velocities in children
with a known history of plumbism. Whether
peripheral neuropathy occurs in asymptomatic
children with no history oflead poisoning remains a
matter of conjecture and is discussed in the follow-
ing section.
Neurological and Behavioral Toxicity of
Chronic Lead Exposure in Children
A growing concern, which has received a great
deal of publicity recently, is the possibility that
chronic, asymptomatic lead exposure may cause
''minimal brain dysfunction," behavior problems,
and neurological impairment in children exposed to
lead in iutero and/or during early childhood. Wiener
(33) reviewed the literature up until 1968. He con-
cluded that methodological shortcomings in all of
the studies made it impossible to draw definitive
conclusions. Weiner notes that:
"Those reports which claimed positive findings
had either used too few cases from which to
generalize or had not provided for controls for
relevant variables such as social class, pica; or
premorbid status. A rigorous statistical and ex-
perimental approach has been conspicuously ab-
sent. Further, the variations in diagnostic proce-
dures and definitions lead to unclear conclusions
regarding the degree oflead ingestion which may
or may not be important for laterdevelopment."
A brief critique of some representative,
frequently-cited studies will indicate that such criti-
cism continues to apply, in varying degrees, to all
subsequent studies. For exmaple, David et al. (34)
suggested an association between lead exposure
and hyperactivity in children. Children, whose
hyperactivity had no known cause, had higher
blood lead levels and body burdens of lead than
normal children or children whose hyperactivity
had a "known cause." However, since the num-
bers in the "known cause"' group were very small,
it cannot be ruled out that lead absorption was sec-
ondary to hyperactivity, particularly since it has
been shown that disturbed children tend to exhibit
an increased incidence of pica (35-37). The statisti-
cal treatment of this study by David et al. (34) has
also been criticized (38).
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(40, 41) compared children with a history of pica
and elevated blood lead levels (40 ug/100 ml and
above), to control children with no history ofpica.
The lead exposed children showed mental impair-
ment, irritability, and poor fine motor control. In
most cases, lead blood concentration was high (>
50 ,ug/100 ml). Although the groups were matched
for race, age, sex, and several socioeconomic vari-
ables, no lead assessments were made for the con-
trol group. Again it can be argued thatchildren with
some history of psychological disturbance (i.e.,
pica) may have other signs ofdisturbance which are
not directly related to lead exposure. Kotok (42)
included pica in addition to age, sex, race, and en-
vironmental factors in matching his controls. He
failed to find significant differences in mental de-
velopment between lead-exposed (blood lead > 40
ugIl/00 ml) and control groups and concluded that
the differences observed were related to home envi-
ronment rather than lead exposure. However, his
controls (many ofthem were siblings ofthe exposed
group) had a mean bloodlead of38,ug/100 ml. Thus,
as many of the controls may have been at high risk
for lead, and Kotok's data must be considered in-
conclusive (43). Other studies suggesting a causa-
tive association of lead exposure with mental im-
pairment have been equally inconclusive (14,
44-47).
The studies described up to this point have dealt
primarily with urban children whose exposure to
lead may come from many sources. Recently, at-
tention has also focused on the effects of chronic
lead exposure in children living in the vicinity ofore
smelters (48-50). McNeil and Ptasnik (51)
evaluated 138 children (21 months-18 years old) liv-
ing near a large ore smelter in operation for about
eight years in El Paso, Texas. Serial blood lead
determinations indicated that these children had
prolonged, asymptomatic elevations in blood lead
levels (40-80,4g/100 ml). They had no neurological
symptoms, and nerve conduction tests were nor-
mal. The authors found no differences in the activ-
ity measurements, and psychometric evaluations of
exposed children and matched controls, living out-
side Smeltertown. They concluded that sustained
blood lead levels of 40-80 ,ug/100 ml had not re-
sulted in any apparent deleterious effects. Land-
rigan et al. (52) also evaluated the neuropsychologi-
calfunction ofagroup ofchildrenlivingin the vicin-
ity ofthe same ore smelter. They concluded that at
blood lead levels of 40-80,g/l00 ml subtle impair-
ment of nonverbal cognitive and perceptual-motor
skills occurred. However, since their controls were
poorly matched with respect to age, history ofpica,
etc., the etiological role of lead cannot be clearly
established. Another study by Landsdown et al.
(53) found no association between blood lead and
intelligence and activity levels of school children
living near a smelter. These authors concluded that
social factors were more important than physical
exposure to lead in determining mental develop-
ment. However, theirsocialfactors were notquanti-
fied and very subjective assessments of behavior
were used (54), thus rendering their conclusions
dubious.
Neurological and psychological evaluations have
also been made on a large, random sample of chil-
dren living near a primary smelter in Shoshone
County, Idaho (55). Landrigan et al. (56) evaluating
matched pairs ofchildren (with 40,ug/100 ml as the
criterion to divide the children into low and high
blood levels) reported a significant correlation be-
tween lead intake and slowing of motor nerve con-
duction velocity. However, Gregory et al. (57) in-
dependently forming their own set ofmatched pairs
(also using 40,ug/100 ml as the standard delineating
point), found no differences in nerve conduction
velocities or intellectual measures between the lead
exposed and control children. Gartside and Panke
(58) reviewed the matched pairing techniques and
statistical analyses used in the Landrigan and Greg-
ory studies. They also noted that in the Landrigan
study only six children (out of 202) had nerve con-
duction velocities below the lower limit of normal
children of similar ages (59). When other matched
pairing and statistical analyses were performed on
the same two groups ofchildren, no significant dif-
ferences were observed. It should be noted that the
use of 40,g/100 ml blood lead level to divide the
pairs in arbitrary. Sets of matchings using different
dividing points might produce different statistical
results. Since conflicting results are produced using
different "Ways to analyze the same data, a signifi-
cant relationship between blood lead level and
nerve conduction velocity in children cannot be re-
garded as established.
The crux of the problem, applicable to all the
studies cited, is that many of the traditional
methodologies, approaches, and data analyses used
to assess the behavioral and neuropsychological
consequences of lead exposure in young children
are open to subjective interpretations. For exam-
ple, the assessment of "hyperkinesis," a syndrome
notwell defined operationally, often relies primarily
on the "impressions" of parents and teachers.
Baloh et al. (46) found that many mothers reported
overactivity in children with elevated lead levels,
but this was not observed in objective behavior rat-
ings by a neurologist or psychologist. On the other
hand, it is difficult to make a valid assessment of
children's behavior for purposes of statistical com-
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the significant, concomitant variables which may
affect activity levels and mental functioning. A per-
sistent reliance upon such traditional approaches
will only succeed in stimulating controversy.
Another general criticism of these studies is that
testing is performed primarily on school age chil-
dren. These studies were unable to document
whether excessive lead absorption, en-
cephalopathy, etc. occurred in infancy and early
childhood, i.e., during the time that suspected brain
damage is most likely to occur. Ideally young
children's intelligence and behavior should be as-
sessed before exposure to lead to determine
whether an elevated lead burden causes or was
caused by defects in mental abilities. Even then,
other causative factors must also be considered.
Thus the data presently available are inadequate to
conclude that subtle psychological, emotional, and
neurological sequelae occur in children as a result
oflead exposure at levels below those causing clini-
cal symptoms.
Neurochemical and Behavioral Toxicity of
Chronic Lead Exposure in Animal Species
In order to obtain more reliable information on
the neurologic and behavioral effects oflead expos-
ure during early development, various experimental
animal models have been employed. Pentschew and
Garro (60) showed that nervous system lesions
similar to those observed in children with lead en-
cephalopathy could be produced in suckling rats by
adding lead to the maternal diet. Rosenblum and
Johnson (61) developed a similar model of lead en-
cephalopathy in suckling mice. In these animal
models extremely high doses of lead were neces-
sary in order to produce symptoms oftoxicity, and
severe growth retardation occurred in the exposed
neonates. Various modifications of these models
have been used in studies on the neurochemical ef-
fects of lead in young rodents. Krigman et al. (62)
observed a delay in myelination accompanied by
decreased concentrations of brain phospholipids,
cholesterol, cerebrosides, and gangliosides in lead-
intoxicated suckling rats. Michaelson and
Sauerhoff (63) observed a 10-20%o reduction in the
DNA content of the cerebellum of lead-exposed
rats. No changes in RNA or protein content were
observed.
Observations on the effects of lead-induced
changes in neurotransmitter metabolism have been
conflicting. Modak et al. (64) observed a decrease
in acetylcholine content in lead-exposed suckling
mice, but Silbergeld and Goldberg (65) did not ob-
serve such changes in mouse brain. In 1973,
Sauerhoffand Michaelson (66) reported no changes
in norepinephrine, but a 20% decrease in dopamine
levels was observed in lead-exposed neonates.
However, in later reports, Golter and Michaelson
(67) were unable to detect changes in dopamine
levels, but found increases in norepinephrine levels
and an enhanced turnover of whole brain
norepinephrine (68). Increases in norepinephrine
but not dopamine levels have also been reported by
Silbergeld et al. (69). Sobotka et al. (70) and Grant
et al. (71) found no changes in monoamine levels
following lead exposure. Many of these studies
were confounded by growth retardation, which may
also affect neurotransmitter metabolism (72), and
thus their significance remains unclear. Studies on
the attenuated behavioral responsiveness of lead-
treated animals to adrenergic pharmacological
agents, such as amphetamine, are consistent and
suggest thatthe monoamine system may be affected
by neonatal lead exposure (73-75).
Table 1 summarizes some of the pertinent litera-
ture on the effects of prenatal and neonatal lead
exposure on the subsequent development and be-
havior of several animal species. Delayed nervous
system development, deficits in visuomotor func-
tion, impaired learning behavior, abnormal social
and aggressive behavior, hyperactivity, hypoactiv-
ity, and no changes in activity have been variously
reported. Many of these studies employed toxic
lead exposure levels. Several recent studies, how-
ever, have examined learning behavior after expos-
ure to relatively low levels of lead (70, 76-78).
These studies suggest that early low-level lead ex-
posure may result in alterations of some subtle and
specific aspects ofbehavior. The nature and signifi-
cance of these alterations have not been deter-
mined, and it is not known whether they were the
result of a direct effect oflead or reflect secondary
changes. The most frequent and most controversial
behavioral measure examined in the studies cited in
Table 1 has been locomotor activity. A brief
analysis of some of these studies indicates that the
investigations on animal models may have confused
rather than clarified the human data.
Sibergeld and Goldberg (79) exposed suckling
mice to 1090-5500 ppm lead acetate through their
mother's milk and at weaning directly through the
drinking water. They reported a threefold increase
in their spontaneous locomotor activity as com-
pared to control mice. Although lead toxicity symp-
toms were not apparent, the growth ofthe lead ex-
posed offspring was significantly retarded, as indi-
cated by reduced body weights and developmental
delays. Thus the nutritional status of the animals
was not adequately considered. Malnutrition con-
founded the early studies ofSauerhoffand Michael-
Environmental Health Perspectives 300Table 1. Behavioral effects of low-level lead exposure in animals.
Parameters of Parameters Effects
Reference Species lead administration measured observed
Xintaras et al. (85) Rat 1.5 mg lead acetate/kg drinking EEG Disturbance in
Brown (86)
Brown (76)
Goode et al. (87)
Allen et al. (88)
Carson et al. (89)
Sobotka et al. (70)
(Albino)
Rat
(Sprague-Dawley)
Rat
(Sprague-Dawley)
Rhesus monkey
Rhesus monkey
Sheep
Rat
Silbergeld and Mouse
Goldberg (79) (CD-1)
Sauerhoff and
Michaelson (66)
Reiter et al. (75)
Rat
(Sprague-Dawley)
Rat
(Sprague-Dawley)
Reiter and Ash (82) Rat
Grant et al. (84)
Hastings et al. (78)
Brady et al. (77)
Rat
(Long-Evans)
H20 for several days at 6-7 wks
Nursing mothers gavaged
(17-35 mg lead acetate/kg)
for 20 days after parturition
Lead acetate, either by gavage to
the dam or IP to the pup
Fed 0.05 mg-5.0 mg lead acetate
in coconut milk for 30 months
Infants: 0.5 mg/kg lead acetate in
formula for 4 wks
Adults: 20 mg/kg in drinking H20
for 4 wks
4.2 mg lead/kg body weight in
diet 4 wks before and
throughout gestation and
lactation
Orally; 5, 15, and 44 mg of lead
acetate/kg body weight for 3 wk
after birth
Nursing mothers receiving
2-10 mg lead acetate/ml
drinking water; at weaning
directly through water
27,300 ppm lead acetate to
nursing mothers; 25 ppm Pb in
diet for 3 wk
5 or 50 ppm lead in drinking
H2O 40 days prior and through-
out gestation and lactation
to adulthood
Nursing mothers receiving 5%
lead carbonate in diet, at
16 days 50 ppm through
drinking water
Stomach intubation 0.01-
200 Ag lead acetate/g body
weight 1-30 days
Nursing mothers receiving
0.2-1.0 mg lead acetate/ml
drinking water for 21 days
Rat
(CFE)
Daily oral intubation (500 mg
of lead acetate) to both males
and females 60 days prior
to mating; females throughout
gestation and lactation.
T-maze learning
T-maze (visual
discrimination)
Spontaneous motor
activity
Conditioned and
delayed response
learning
"Systematic"
observation of
behavior
Visual discrimina-
tion learning
General locomotor
activity
Exploratory activity
Passive avoidance
Learning behavior
Habit-reversal
Operant task
Locomotor activity
Locomotor activity
Reflex development
Locomotor activity
in residential maze
Locomotor activity
in residential maze
Aggression towards
mice
T-maze learning
operant conditioning
Locomotor activity
Spontaneous activity
Shock-induced
aggressive behavior
Acquisition and
performance of a
visual discrimination
task (water T-maze)
REM sleep
Decreased learning
Impaired learning
no changes in
activity
No effect
Infants: Hyperactivity.
insomnia, abnormal
social behavior
Adults: No effect
Performance
deficit
No effects
Impaired
performance
3-fold increase
in activity
40-93%/r increase
in activity
H-lypoactivity
delay in righting
reflex
Hypoactivity
No persistent
effects
No changes in
actlVItv
r-eduLced aggression
Per-formnance
deficit
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ous activity in the offspring ofnursing rats exposed
to 27,300 ppm lead acetate in the diet. In a subse-
quent study, Golter and Michaelson (67) found that
oral administration of lead acetate to suckling rats
did not affect their growth rate, but that these rats
continued to exhibit periods of increased motor ac-
tivity. However, spurious activity measurements
could have occurred in either their control or ex-
perimental groups; since these investigators tested
the activity of six siblings simultaneously without
specifying the sexual composition of each litter.
The more crucial issue, however, is that the doses
of lead administered, resulted in malnourished
offspring. Michaelson et al. (80) recently reported
that early undernutrition, comparable to that fre-
quently reported in lead-exposed mice, resulted in
enhanced spontaneous locomotor activity. Castel-
lano and Oliverio (81) also reported that mal-
nourishment caused increased exploratory activity
and impaired avoidance behavior in mice. Sobotka
et al. (74) found that malnourished weanling rats
displayed a state ofheightened "emotionality" and
impaired learning behavior. Thus some of the be-
havioral reponses seen in these lead exposed ro-
dents may be due to early undernutrition.
Reiter et al. (75, 82) investigated possible effects
ofthe nutritional status oflead-exposed rats, as well
as some ofthe parameters used to assay locomotor
activity. When Reiter and Ash (82) exposed male
rat pups to high doses of lead via their mother's
milk (nursing mothers received 5% lead carbonate
in the diet), and after 16 days directly through the
drinking water (50 ppm), they observed that food
consumption was reduced in the lead treated dams
with a corresponding reduction in the growth ofthe
pups. Delays in the development of the startle re-
sponse, eye opening, and righting reflex were ob-
served in both lead-treated and pair-fed animals;
thus indicating that these developmental delays
may be due to malnutrition. Lead-treated animals
showed an initial hyperactivity at two weeks, which
returned to control levels by 6 weeks. When
locomotor activity in a residential maze was mea-
sured in adults, no treatment differences were ob-
served. When Reiter et al. (75) exposed rats (40
days prior to and throughout gestation and lactation
to adulthood) to low levels of lead acetate in the
drinking water (5 or 50 ppm), delays in the de-
velopment of the righting reflex and in eye opening
were observed, butbody weights were not affected.
Locomotor activity of adult males was monitored
day and nightforfive consecutive days in aresiden-
tial maze. On the first test day, hypoactivity was
observed in adult lead-treated animals during all
periods of the activity cycle. On subsequent days,
no changes in diurnal activity were observed, but
nocturnal activity was depressed. These authors
suggested that lead treatment may result in a tem-
porary increase in locomotor activity in response to
a novel environment in young animals, followed by
hypoactivity in adult organisms. The recent obser-
vation by Reiter (83), that lead treatment may dis-
rupt the normal activity cycles of rats, may also
explain some of the conflicting results, since most
studies have monitored activity levels for only brief
periods oftime (hours), rather than for consecutive
days. Studies (70, 78, 84) using lead exposures not
resulting in reduced body weights have not found
any persistent changes in the activity levels of the
exposed rats.
Thus, all possible variations in locomotoractivity
(hypoactivity, hyperactivity, no change in activity)
as a result of lead treatment have been observed.
Some of the confusion is probably due to the wide
differences in the doses of lead administered; the
chemical form, route, and timing oflead administra-
tion; the concomitant nutritional state of the ani-
mals; and the technology used to assess locomotor
activity. In most studies no attempts were made to
assess the internal dose oflead by measuring tissue
or blood lead levels during the critical periods of
brain development. Unwarranted generalizations
and extrapolations from limited behavioral mea-
sures hiave frequently been made. Thus, unfortu-
nately, at the present time the animal data remain
inconclusive.
Effects of Lead on the
Renal System
Goyer and Rhyne (4) reviewed the pathological
effects oflead exposure onthe renal systems ofman
and animals. Clinically demonstrable effects in man
occur only in association with other symptoms of
lead toxicity. Studies in man and experimental ani-
mals indicate that chronic kidney effects are also
the result of a high renal lead content for a pro-
longed period oftime. There are no reports suggest-
ing that kidney damage occurs in asymptomatic
cases. The duration and degree of lead exposure
necessary to produce irreversible kidney damage is
not known. Malignant renal tumors have been pro-
duced in mice and rats fed 0.1% or 1% lead acetate
(90-92). Benign and malignant kidney tumors were
observed in rats fed lead acetate (3 mg/day for 2
months and 4 mg/day for 16 months); besides the
kidney tumors, neoplasms of the testes, adrenals,
thyroid, pituitary, and prostate were also observed
(93). In male Sprague-Dawley rats on a diet con-
taining 1% lead subacetate, two gliomas were ob-
served besides 13 kidney tumors in 17 animals (94).
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over a 16-month period, produced adenomas, papil-
lomas, and cystadenomas of the renal cortex in al-
bino rats. The total dose oflead administered varied
between 120 and 680 mg Pb in the animals getting
tumors (95). No positive findings have been re-
ported on humans exposed to high levels of lead.
Dingwall-Fordyce and Lane (96) followed 425 re-
tirees and others with long exposure to lead in a
battery factor. They found no increase in cancer in-
cidence but saw an excess in cerebrovascular acci-
dents. There are sufficientpublications on ill effects
of lead exposure of humans that cases of cancer in
these people, even if anecdotal, would have been
reported in the literature over the years. When the
experimental data on rodents are used for extrapo-
lation to human exposure, the equivalent dose for
renal tumor development in man would be 550 mg
lead per day which appears to exceed the maximum
tolerated dose oflead for man (97). Lead is thus not
considered a human carcinogen.
Effects of Lead on
Other Organ Systems
Effects on Chromosomes
Contradictory results have been published in the
last few years with respect to a suggested increased
occurrence of chromosome aberrations in workers
occupationally exposed to lead. Schmid et al. (98)
found no evidence of increased chromosome aber-
rations in lead manufacturing workers; in policemen
with increased blood lead levels (99); or in male
workers exposed to lead oxide fumes in a ship-
breaking yard (100). However, an increase in
chromosome aberrations in people occupationally
exposed to lead has been reported by Forni and
Secchi (101); Schwanitz et al. (102), and DeKnudt
etal. (103). Unfortunately, mostofthese studies are
based on very few (10-20) subjects. A study by
Forni and Secchi (104) showed that the rates of
chromatid changes were higher in 65 workers with
preclinical and clinical signs of lead poisoning but
were not significantly raised in workers with past
poisoning. Forni et al. (105) also examined 11 sub-
jects before and during initial exposure to lead. The
increase in rate ofabnormal chromatid metaphases
was doubled after one month of exposure, was
further increased after 2 months, remained in this
stage up to 7 months, and then decreased. The fact
that most alterations were of the chromatid type
(i.e., occurring in cell culture after DNA synthesis)
indicates that these may be culture-produced aber-
rations, not repaired in the presence of lead, and
may not reflect a real in vivo situation. Thus the
biological significance is unknown.
Effects on Reproduction
It has been reported since antiquity that lead
compounds can be used as abortifacients, and that
lead poisoning is associated with reduced fertility,
miscarriages, and stillbirths (106). Little evidence is
available as to whether subtoxic levels oflead affect
fertility or cause fetal injuries in man. Lancranjan et
al. (107) reported that moderate absorption of lead
(blood Pb 50-80,ug/100 ml) in male workers resulted
in hypospermia and teratospermia. A slightly in-
creased absorption of lead had no such effects. A
recent study by Fahim etal. (108) suggests that sub-
toxic lead absorption during pregnancy may be as-
sociated with an increased incidence ofpreterm de-
livery and early membrane rupture. A high correla-
tion was found between lead concentration in ma-
ternal and fetal blood; both were significantly
higher in the preterm pregnancies and early mem-
brane ruptures than in term pregnancies. However,
these authors offer no explanation for the large dif-
ferences they observed between maternal and fetal
blood lead levels. Other studies have shown that
the quantities of lead present in newborn infants
generally reflect that of their mother (109-112). An
analysis of human fetal tissues (113) demonstrated
that placental transfer oflead begins as early as the
12th week of gestation and that total lead content
increases throughout pregnancy, with the highest
concentrations occurring in bone, kidney, and liver;
but significant amounts are also present in blood,
brain, and heart. However, as Barltrop (113) has
pointed out, the distribution oflead within the fetus
at different stages ofdevelopment is probably more
important than the total amount present at birth.
Several animal studies indicate that lead expos-
ure may impair the reproductive ability of both
males and females. Schroeder and Mitchener (114)
observed that lead-exposed mice produced fewer
litters, and that many of the offspring had reduced
body weights and experienced early death. Stowe
and Goyer (115) studied the paternal and maternal
effects of lead on the reproductive performance of
normal and lead-exposed F1 offspring. Reduced
birth weight, growth, retardation, and decreased
postnatal survival were observed in the lead-
intoxicated rats. The authors made no assessment
of lead body burden. Hilderbrand et al. (116) ob-
served that sexually mature male rats exposed to
lead acetate for 30 days exhibited impotence and
prostatic hyperplasia at blood lead levels of 14-26
,ug/100 ml, and testicular damage at blood lead
levels of 50-100,g/100 ml. Similarly exposed
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cycle at blood lead levels of 14-30 ,Ag/100 ml and
ovarian cysts at blood lead levels of 50-100 ,Lg/100
ml. Der et al. (117) exposed 21-day old female rats
daily to subcutaneous injections of lead acetate for
40 days. A delay in vaginal opening and onset of
estrous was observed in lead-treated females (blood
lead, 60,g/100 ml) fed a normal protein diet. Vagi-
nal opening and estrous cycles never occurred in
females treated with lead (blood lead, 108 Ag/100
ml) and fed a low protein diet.
Although malformations have not been observed
in most experimental investigations, a few studies
have demonstrated a teratogenic effect of lead.
Urorectocaudal malformations were produced in
rats (118), and tail abnormalities in hamsters (119)
as a result ofintravenous lead administration during
early gestation. Cardiac abnormalities have also
been reported after treating chick embryos with
lead (120). All these studies employed acute dos-
ages of lead. There are no convincing reports that
lead in teratogenic in humans.
Little is known about the effects oflead on repro-
ductive performance and postnatal development
following chronic, low-level exposure. Kimmel et
al. (121) exposed female rats chronically to lead
acetate via the drinking water (0.5, 5, 50, 250 ppm)
from weaning through mating, gestation, and lacta-
tion. Vaginal opening was delayed 1-2 weeks, in
females exposed to 50 and 250 ppm lead, but es-
trous cycles and pregnancy rates were normal. No
teratogenic effects were observed, although expos-
ure to 250 ppm lead acetate caused a slight, but
nonsignificant increase in fetal resorptions. The
lead-treated animals produced litters of normal
numbers, but the offspring from the 50 and 250 ppm
groups weighed less at weaning and showed delays
in physical development. Reiter et al. (75) also ob-
served developmental delays in rat offspring ex-
posed to 50 ppm lead throughout gestation and lac-
tation. Whether these delays in development were
the result of a direct effect of lead on the nervous
system of the pups or reflect secondary changes
(malnutrition, hormonal imbalance, etc.) is not
clear. Whatever the mechanisms involved, these
studies do suggest that low-level chronic exposure
to lead might induce postnatal developmental de-
lays.
Effects on the Immune System
Several studies in animal models have suggested
that lead may interfere with various aspects of the
immune response. Lead has been reported to result
in an increased susceptibility to infection in mice
and rats. Selye et al. (122) found that rats injected
with lead acetate (minimal) effective dose 1 mg/100 g
body weight) were susceptible to a variety ofbacter-
ial endotoxins to which this species is usually
resistant. This susceptibility occurred only when
lead and the endotoxin were administered either
simultaneously or within several hours of each
other. Hemphill et al. (123) found that mice injected
with subclinical doses of lead nitrate for 30 days
showed a reduced resistance to Salmonella
typhimurium. Gainer (124) observed that administ-
ration of lead aggravated the response of mice to
viruses. Various factors may be involved in produc-
ing this enhanced susceptibility to infection. Lead
can bind to antibodies (125) and when administered
orally it diminished the level of circulating an-
tibodies in mice (126). Trejo et al. (127) observed
that an intravenous injection of lead had no effect
on antibody production in rats, but impaired their
phagocytotic activity. Vengris and Mare (128)
found no immunosuppression in chickens fed lead
acetate and challenged with Newcastle disease
virus, but toxic levels of lead suppressed the in-
terferon response. Bingham et al. (129) found that
the inhalation by rats of lead sesquioxide aerosol
(10 ,ug/m3) significantly reduced the number of al-
veolar macrophages. Bruch et al. (130) found that
rats inhaling particulate lead oxide (200 ug/m3)
showed mitochondrial and endoplasmic reticular
damage ofalveolar macrophages and pneumocytes,
and exhibited a considerable loss in the activity of
the benzopyrene hydroxylating enzyme. Further
studies are needed in order to determine and under-
stand the effects oflead on immune mechanisms in
animal models. A difficulty in determining the ef-
fects of lead on the immune system of children, is
that urban, lead-exposed children are also likely to
be at high risk for contracting infectious diseases.
Reigart and Graber (131) found that 12 children
with blood lead levels of 41-51 ,g/100 ml did not
differ from 7 children with blood lead levels of7-13
,g/100 ml with respect to complement levels, im-
munoglobulins, or anamnestic response to tetanus
toxoid antigen. There do not appear to be any sys-
tematic epidemiological investigations on the ef-
fects of elevated lead levels on the incidence of in-
fectious diseases in man (132).
Effects on the Endocrine System
Excessive exposure to lead has been associated
with an impairment of endocrine function in both
man and experimental animals. The uptake of
iodine and its conversion to protein-bound iodine
was retarded in lead-intoxicated rats (133). Iodine
uptake was also decreased in lead-poisoned pa-
tients, but this effect could be overcome by ex-
Environmental Health Perspectives 304ogenous administration of thyroid-stimulating hor-
mone (134). High lead levels resulted in adecreased
secretion of pituitary hormones (135) and an im-
pairment ofadrenal gland functioning (136) in lead-
poisoned patients. Whether low-level chronic lead
exposure can affect pituitary, adrenal, and thyroid
to be determined.
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